Who owns Outset Medical, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of OM from SEC Form 13F filings across 77 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 77 institutions disclosed 12.2M shares of Outset Medical, Inc. worth $36.7M — about 64.9% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
77
13F holders
$36.7M
value, 2026 filers
64.9%
of shares outstanding (12.2M sh)
9
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of OM's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 2.7M | $8.2M | 0.0% | 14.5% | -0.2% |
| 2 | BML Capital Management, LLC | 2.5M | $7.6M | 4.0% | 13.4% | 0.0% |
| 3 | PERCEPTIVE ADVISORS LLC | 833,333 | $2.5M | 0.0% | 4.4% | 0.0% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 780,134 | $2.3M | 0.0% | 4.1% | 0.0% |
| 5 | BANK OF AMERICA CORP /DE/ | 667,437 | $2.0M | 0.0% | 3.5% | +0.2% |
| 6 | PFM Health Sciences, LP | 582,122 | $1.7M | 0.2% | 3.1% | 0.0% |
| 7 | MARSHALL WACE, LLP | 483,380 | $1.5M | 0.0% | 2.6% | +128.0% |
| 8 | BlackRock, Inc. | 366,597 | $1.1M | 0.0% | 1.9% | -12.3% |
| 9 | AQR CAPITAL MANAGEMENT LLC | 343,061 | $1.0M | 0.0% | 1.8% | -65.7% |
| 10 | Assenagon Asset Management S.A. | 339,438 | $1.0M | 0.0% | 1.8% | 0.0% |
| 11 | Peapod Lane Capital LLC | 337,090 | $1.0M | 0.8% | 1.8% | +1.5% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 208,964 | $627,203 | 0.0% | 1.1% | +2.1% |
| 13 | Clayton Partners LLC | 200,000 | $600,000 | 0.4% | 1.1% | +432.9% |
| 14 | ACADIAN ASSET MANAGEMENT LLC | 189,004 | $565,000 | 0.0% | 1% | +439.2% |
| 15 | MORGAN STANLEY | 145,493 | $436,479 | 0.0% | 0.8% | -20.1% |
| 16 | MILLENNIUM MANAGEMENT LLC | 140,489 | $421,467 | 0.0% | 0.7% | -22.7% |
| 17 | VANGUARD FIDUCIARY TRUST CO | 114,912 | $344,736 | 0.0% | 0.6% | 0.0% |
| 18 | Catalio Capital Management, LP | 107,456 | $322,368 | 0.1% | 0.6% | -9.2% |
| 19 | GMT Capital Corp | 98,108 | $294,324 | 0.0% | 0.5% | 0.0% |
| 20 | DIMENSIONAL FUND ADVISORS LP | 90,698 | $272,132 | 0.0% | 0.5% | 0.0% |
| 21 | XTX Topco Ltd | 81,149 | $243,447 | 0.0% | 0.4% | -34.9% |
| 22 | UBS Group AG | 79,129 | $237,387 | 0.0% | 0.4% | -58.4% |
| 23 | STATE STREET CORP | 78,395 | $235,185 | 0.0% | 0.4% | -3.5% |
| 24 | C WorldWide Group Holding A/S | 66,666 | $200,000 | 0.0% | 0.4% | 0.0% |
| 25 | RENAISSANCE TECHNOLOGIES LLC | 60,628 | $181,884 | 0.0% | 0.3% | +39.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.